UBS Group AG - LION BIOTECHNOLOGIES INC ownership

Quarter-by-quarter ownership
UBS Group AG ownership history of LION BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2017$186,000
-83.6%
25,000
-84.6%
0.00%
-100.0%
Q4 2016$1,131,000
-53.1%
162,770
-44.4%
0.00%0.0%
Q3 2016$2,412,000
+6.9%
293,008
+5.1%
0.00%0.0%
Q2 2016$2,257,000
+60.5%
278,706
+0.7%
0.00%0.0%
Q1 2016$1,406,000
-39.6%
276,715
-8.2%
0.00%
-50.0%
Q4 2015$2,326,000
+12.8%
301,319
-15.8%
0.00%
+100.0%
Q3 2015$2,062,000
-29.7%
358,000
+11.8%
0.00%
-50.0%
Q2 2015$2,935,000
+19.1%
320,100
+57.3%
0.00%0.0%
Q1 2015$2,464,000203,5000.00%
Other shareholders
LION BIOTECHNOLOGIES INC shareholders Q2 2017
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 3,232,416$26,183,00012.58%
Avoro Capital Advisors LLC 4,338,557$35,142,0007.81%
FRAZIER MANAGEMENT LLC 774,720$6,275,0005.00%
Broadfin Capital, LLC 3,170,759$25,683,0002.50%
Perceptive Advisors 3,611,976$29,257,0002.03%
Ghost Tree Capital, LLC 700,000$5,670,0001.64%
Opaleye Management Inc. 260,000$2,106,0001.41%
Rhenman & Partners Asset Management AB 650,000$5,265,0000.94%
QVT Financial LP 1,598,309$12,946,0000.89%
Cormorant Asset Management, LP 505,941$4,098,0000.58%
View complete list of LION BIOTECHNOLOGIES INC shareholders